Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-18

Clinical Trial Update: Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, tolerability, and pharmacokinetics of OZ439 in adults with acute, uncomplicated malaria due to Plasmodium falcip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZ439

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria, Falciparum, Malaria, Vivax | Phase 2 | Status: COMPLETED | Results posted: 2014-11-18